EUVIMEDEUVIMED entdecken
Crossref

Disparities in cancer incidence and stage at diagnosis between male and female patients in the Netherlands

Liza A Hoveling, Anouk Eijkelboom, Melinda Schuurman, Christina Bode, Vera Atema, Hanneke W M van Laarhoven, Sabine Oertelt-Prigione, Anke Richters, Kristel M van Asselt, Sabine Siesling, Mieke J Aarts

European Journal of Cancer · 2025

DOI: 10.1016/j.ejca.2025.116063 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cancer, 2025. Verfasst von Liza A Hoveling und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Technology and Services Research, Technical Medical Centre, University of Twente, Enschede, the Netherlands; Department of Resea…. Hauptthemen laut MEDLINE: Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 47 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: We investigated how sex differences in incidence of cancer and stage at diagnosis manifest across age groups. METHODS: A retrospective cohort study was performed based on data from the Netherlands Cancer Registry (NCR). Adult patients diagnosed with one of the top 10 not-sex-specific cancers in the Netherlands between 2017 and 2022 were included. Tumour incidence and stage at diagnosis were analysed using age-standardized and sex-specific incidence rate ratios (IRR), with 95 % confidence intervals. RESULTS: The 10 most frequent cancers affected 194,304 patients of which 43 % were female. Median age at diagnosis was 72 years for males and 71 years for females. Incidence rate ratios showed no difference between sexes aged 18-49 (IRR=1.00), but higher rates in males aged 50-69 (IRR=1.34) and ≥ 70 (IRR=1.76). Largest IRR differences (IRR>3.00) were observed for bladder, urinary tract cancers, and oesophageal cancers. Stage IV was the most frequent stage overall, particularly for lung, pancreatic, and oesophageal cancers, though this varied by cancer type. Males were diagnosed at more advanced stages, especially for oesophageal and head and neck cancers. Bladder cancer was mainly stage 0, melanoma stage I, and colorectal cancer stage III in males and stage I in females. CONCLUSIONS: Our study showed sex- and age-specific differences in cancer incidence and stage at diagnosis, with males showing higher incidence rates. Males were also diagnosed at more advanced stage. These findings underline the importance of taking both sex and age into account in cancer prevention and early detection strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsHumansFemaleMaleNetherlandsMiddle AgedAgedIncidenceRetrospective StudiesAdultAdolescentNeoplasm StagingYoung AdultAged, 80 and overRegistriesSex FactorsAge Factors

Stichwörter der Autor:innen

Cancer incidenceEarly detectionNetherlands Cancer RegistrySex and age disparitiesStage at diagnosis

Autor:innen und Institutionen

  • Department of Health Technology and Services Research, Technical Medical Centre, University of Twente, Enschede, the Netherlands; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IK…
  • Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands.
  • Department of Psychology, Health and Technology, University of Twente, Enschede, the Netherlands.
  • Amsterdam UMC location University of Amsterdam, Department of Medical Oncology, Amsterdam, the Netherlands; Cancer Center Amsterdam, Cancer Treatment and Quality of Life, Amsterdam, the Netherlands.
  • Sex, and Gender-Sensitive Medicine Department, Medical Faculty OWL, University of Bielefeld, Bielefeld, Germany; Gender Unit, Department of Primary and Community Care, Radboud University, Nijmegen, the Netherlands.
  • Department of General Practice and Nursing Science, UMC Utrecht, Utrecht, the Netherlands.

Zitieren

APA

Hoveling, L. A., Eijkelboom, A., Schuurman, M., Bode, C., Atema, V., van Laarhoven, H. W. M., Oertelt-Prigione, S., Richters, A., van Asselt, K. M., Siesling, S., & Aarts, M. J. (2025). Disparities in cancer incidence and stage at diagnosis between male and female patients in the Netherlands. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2025.116063

Vancouver

Hoveling LA, Eijkelboom A, Schuurman M, Bode C, Atema V, van Laarhoven HWM, et al. Disparities in cancer incidence and stage at diagnosis between male and female patients in the Netherlands. European Journal of Cancer. 2025. doi:10.1016/j.ejca.2025.116063

BibTeX
@article{Hoveling2025,
  author = {Hoveling, Liza A and Eijkelboom, Anouk and Schuurman, Melinda and Bode, Christina and Atema, Vera and van Laarhoven, Hanneke W M and Oertelt-Prigione, Sabine and Richters, Anke and van Asselt, Kristel M and Siesling, Sabine and Aarts, Mieke J},
  title = {Disparities in cancer incidence and stage at diagnosis between male and female patients in the Netherlands},
  journal = {European Journal of Cancer},
  year = {2025},
  doi = {10.1016/j.ejca.2025.116063}
}
Kostenlos starten →